STOCK TITAN

[Form 4] UNITEDHEALTH GROUP INCORPORATED (Delaware) Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

UnitedHealth Group director Paul R. Garcia reported insider trading activity on June 24, 2025. The transaction involved the acquisition of 11 shares of Common Stock as dividend equivalents paid on vested deferred stock units, received at $0 price.

Following the transaction, Garcia's beneficial ownership consists of:

  • 2,481 shares held directly
  • 2,146 shares held indirectly through a Revocable Trust
  • 45 shares held indirectly through Trust 2
  • 55 shares held indirectly through Trust 3

The dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units. The Form 4 was filed by attorney-in-fact Faraz A. Choudhry on June 26, 2025.

Il direttore di UnitedHealth Group, Paul R. Garcia, ha segnalato un'operazione di insider trading il 24 giugno 2025. La transazione ha riguardato l'acquisizione di 11 azioni di azioni ordinarie come equivalenti di dividendi pagati su unità azionarie differite maturate, ricevute a un prezzo di 0 $.

A seguito della transazione, la proprietà effettiva di Garcia comprende:

  • 2.481 azioni detenute direttamente
  • 2.146 azioni detenute indirettamente tramite un Trust Revocabile
  • 45 azioni detenute indirettamente tramite Trust 2
  • 55 azioni detenute indirettamente tramite Trust 3

Gli equivalenti di dividendi sono stati immediatamente maturati e sono soggetti alle stesse condizioni delle unità azionarie differite sottostanti. Il modulo 4 è stato presentato dall’avvocato delegato Faraz A. Choudhry il 26 giugno 2025.

El director de UnitedHealth Group, Paul R. Garcia, reportó una actividad de operaciones con información privilegiada el 24 de junio de 2025. La transacción involucró la adquisición de 11 acciones de acciones comunes como equivalentes de dividendos pagados sobre unidades de acciones diferidas adquiridas, recibidas a un precio de 0 $.

Tras la transacción, la propiedad beneficiaria de Garcia consiste en:

  • 2,481 acciones en propiedad directa
  • 2,146 acciones en propiedad indirecta a través de un Fideicomiso Revocable
  • 45 acciones en propiedad indirecta a través del Fideicomiso 2
  • 55 acciones en propiedad indirecta a través del Fideicomiso 3

Los equivalentes de dividendos se adquirieron inmediatamente y están sujetos a los mismos términos que las unidades de acciones diferidas subyacentes. El Formulario 4 fue presentado por el apoderado Faraz A. Choudhry el 26 de junio de 2025.

UnitedHealth Group의 이사 Paul R. Garcia는 2025년 6월 24일 내부자 거래 활동을 보고했습니다. 이 거래는 확정된 연기 주식 단위에 대한 배당금 상당액으로서 11주의 보통주를 0달러 가격에 취득하는 것이 포함되었습니다.

거래 이후 Garcia의 실질 소유권은 다음과 같습니다:

  • 2,481주 직접 보유
  • 2,146주 취소 가능한 신탁을 통한 간접 보유
  • 45주 신탁 2를 통한 간접 보유
  • 55주 신탁 3를 통한 간접 보유

배당금 상당액은 즉시 확정되었으며 기초 연기 주식 단위와 동일한 조건이 적용됩니다. 폼 4는 대리인 Faraz A. Choudhry에 의해 2025년 6월 26일 제출되었습니다.

Le directeur de UnitedHealth Group, Paul R. Garcia, a déclaré une opération d’initié le 24 juin 2025. La transaction concernait l’acquisition de 11 actions ordinaires en équivalents de dividendes versés sur des unités d’actions différées acquises, reçues à un prix de 0 $.

Après la transaction, la propriété bénéficiaire de Garcia se compose de :

  • 2 481 actions détenues directement
  • 2 146 actions détenues indirectement via un trust révocable
  • 45 actions détenues indirectement via le Trust 2
  • 55 actions détenues indirectement via le Trust 3

Les équivalents de dividendes ont été immédiatement acquis et sont soumis aux mêmes conditions que les unités d’actions différées sous-jacentes. Le formulaire 4 a été déposé par le mandataire Faraz A. Choudhry le 26 juin 2025.

Paul R. Garcia, Direktor von UnitedHealth Group, meldete am 24. Juni 2025 Insiderhandel-Aktivitäten. Die Transaktion umfasste den Erwerb von 11 Aktien von Stammaktien als Dividendenäquivalente, die auf unverfallbaren, aufgeschobenen Aktienanteilen basieren, zu einem Preis von 0 $.

Nach der Transaktion besteht Garcias wirtschaftliches Eigentum aus:

  • 2.481 Aktien direkt gehalten
  • 2.146 Aktien indirekt über einen widerruflichen Trust gehalten
  • 45 Aktien indirekt über Trust 2 gehalten
  • 55 Aktien indirekt über Trust 3 gehalten

Die Dividendenäquivalente wurden sofort unverfallbar und unterliegen den gleichen Bedingungen wie die zugrundeliegenden aufgeschobenen Aktienanteile. Das Formular 4 wurde am 26. Juni 2025 vom Bevollmächtigten Faraz A. Choudhry eingereicht.

Positive
  • None.
Negative
  • None.

Il direttore di UnitedHealth Group, Paul R. Garcia, ha segnalato un'operazione di insider trading il 24 giugno 2025. La transazione ha riguardato l'acquisizione di 11 azioni di azioni ordinarie come equivalenti di dividendi pagati su unità azionarie differite maturate, ricevute a un prezzo di 0 $.

A seguito della transazione, la proprietà effettiva di Garcia comprende:

  • 2.481 azioni detenute direttamente
  • 2.146 azioni detenute indirettamente tramite un Trust Revocabile
  • 45 azioni detenute indirettamente tramite Trust 2
  • 55 azioni detenute indirettamente tramite Trust 3

Gli equivalenti di dividendi sono stati immediatamente maturati e sono soggetti alle stesse condizioni delle unità azionarie differite sottostanti. Il modulo 4 è stato presentato dall’avvocato delegato Faraz A. Choudhry il 26 giugno 2025.

El director de UnitedHealth Group, Paul R. Garcia, reportó una actividad de operaciones con información privilegiada el 24 de junio de 2025. La transacción involucró la adquisición de 11 acciones de acciones comunes como equivalentes de dividendos pagados sobre unidades de acciones diferidas adquiridas, recibidas a un precio de 0 $.

Tras la transacción, la propiedad beneficiaria de Garcia consiste en:

  • 2,481 acciones en propiedad directa
  • 2,146 acciones en propiedad indirecta a través de un Fideicomiso Revocable
  • 45 acciones en propiedad indirecta a través del Fideicomiso 2
  • 55 acciones en propiedad indirecta a través del Fideicomiso 3

Los equivalentes de dividendos se adquirieron inmediatamente y están sujetos a los mismos términos que las unidades de acciones diferidas subyacentes. El Formulario 4 fue presentado por el apoderado Faraz A. Choudhry el 26 de junio de 2025.

UnitedHealth Group의 이사 Paul R. Garcia는 2025년 6월 24일 내부자 거래 활동을 보고했습니다. 이 거래는 확정된 연기 주식 단위에 대한 배당금 상당액으로서 11주의 보통주를 0달러 가격에 취득하는 것이 포함되었습니다.

거래 이후 Garcia의 실질 소유권은 다음과 같습니다:

  • 2,481주 직접 보유
  • 2,146주 취소 가능한 신탁을 통한 간접 보유
  • 45주 신탁 2를 통한 간접 보유
  • 55주 신탁 3를 통한 간접 보유

배당금 상당액은 즉시 확정되었으며 기초 연기 주식 단위와 동일한 조건이 적용됩니다. 폼 4는 대리인 Faraz A. Choudhry에 의해 2025년 6월 26일 제출되었습니다.

Le directeur de UnitedHealth Group, Paul R. Garcia, a déclaré une opération d’initié le 24 juin 2025. La transaction concernait l’acquisition de 11 actions ordinaires en équivalents de dividendes versés sur des unités d’actions différées acquises, reçues à un prix de 0 $.

Après la transaction, la propriété bénéficiaire de Garcia se compose de :

  • 2 481 actions détenues directement
  • 2 146 actions détenues indirectement via un trust révocable
  • 45 actions détenues indirectement via le Trust 2
  • 55 actions détenues indirectement via le Trust 3

Les équivalents de dividendes ont été immédiatement acquis et sont soumis aux mêmes conditions que les unités d’actions différées sous-jacentes. Le formulaire 4 a été déposé par le mandataire Faraz A. Choudhry le 26 juin 2025.

Paul R. Garcia, Direktor von UnitedHealth Group, meldete am 24. Juni 2025 Insiderhandel-Aktivitäten. Die Transaktion umfasste den Erwerb von 11 Aktien von Stammaktien als Dividendenäquivalente, die auf unverfallbaren, aufgeschobenen Aktienanteilen basieren, zu einem Preis von 0 $.

Nach der Transaktion besteht Garcias wirtschaftliches Eigentum aus:

  • 2.481 Aktien direkt gehalten
  • 2.146 Aktien indirekt über einen widerruflichen Trust gehalten
  • 45 Aktien indirekt über Trust 2 gehalten
  • 55 Aktien indirekt über Trust 3 gehalten

Die Dividendenäquivalente wurden sofort unverfallbar und unterliegen den gleichen Bedingungen wie die zugrundeliegenden aufgeschobenen Aktienanteile. Das Formular 4 wurde am 26. Juni 2025 vom Bevollmächtigten Faraz A. Choudhry eingereicht.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GARCIA PAUL R

(Last) (First) (Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE

(Street)
EDEN PRAIRIE MN 55344

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/24/2025 A 11(1) A $0 2,481 D
Common Stock 2,146 I By Revocable Trust
Common Stock 45 I By Trust 2
Common Stock 55 I By Trust 3
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for Paul R. Garcia 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction occurred at UNH on June 24, 2025?

Director Paul R. Garcia acquired 11 shares of UNH common stock at $0 per share through dividend equivalents paid on vested deferred stock units. These dividend equivalents vested immediately and are subject to the same terms as the underlying deferred stock units.

How many UNH shares does Director Paul Garcia own directly after this transaction?

Following the reported transaction, Paul Garcia directly owns 2,481 shares of UNH common stock.

What is the total indirect ownership of UNH shares by Paul Garcia?

Paul Garcia indirectly owns a total of 2,246 shares of UNH through various trusts: 2,146 shares in a Revocable Trust, 45 shares in Trust 2, and 55 shares in Trust 3.

Who filed this Form 4 for UNH and when was it filed?

The Form 4 was filed by Faraz A. Choudhry, serving as Attorney-in-Fact for Paul R. Garcia, on June 26, 2025.

What type of insider transaction triggered this UNH Form 4 filing?

The Form 4 was triggered by the acquisition of dividend equivalents on vested deferred stock units, which resulted in the immediate vesting of 11 additional shares at $0 cost basis.
Unitedhealth Gp

NYSE:UNH

UNH Rankings

UNH Latest News

UNH Latest SEC Filings

UNH Stock Data

273.97B
904.46M
0.24%
90.3%
0.95%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
EDEN PRAIRIE